CLINICAL_TRIALS
trial_result
· 2025-12-30
Clinical Trial Update: Nivolumab Consolidation in Older (≥ 65) Patients With Primary CNS Lymphoma [Phase 1]
Summary
A Phase 1 trial evaluating nivolumab as consolidation therapy in older adults (≥65) with primary central nervous system lymphoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Wake Forest University Health Sciences | Conditions: Brain and Nervous System, Eye and Orbit | Phase 1 | Status: COMPLETED